Mark L. Gonzalgo, M.D., Ph.D.
Publication Details
-
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Urol Oncol. 2012 Jul-Aug; (4): 428-33
Elevated polycomb group protein Enhancer of Zest Homolog 2 (EZH2) expression has been associated with progression to more advanced disease in a variety of malignancies. We examined EZH2 protein expression levels in bladder tissue specimens from patients with urothelial carcinoma (UC) and investigated the relationship between EZH2 protein expression and clinical outcomes.
Help
Trial Administration